Revenue rose to EUR396m from EUR312m.
CompuGroup also said it forecasts its revenue to amount to between EUR440m and EUR460m in 2012, while EBITDA is seen at between EUR95m and EUR105m.
The final financial results for 2011 will be published on 29 March 2012.
(EUR 1.0 = USD 1.315)
Abbott announces quarterly dividend
Aptamer Optimer technology integrated into Twist Bioscience TrueAmp Library Preparation Kit
Alvotech reports positive PK study results for AVT80 biosimilar candidate
Inspiration Healthcare secures US purchasing agreement to drive Airon growth
West to sell SmartDose 3.5mL On-Body Delivery System rights to AbbVie for USD112.5m
Citius Pharmaceuticals reports full-year financial results
Sanofi receives FDA complete response letter for tolebrutinib in progressive MS
Abbott announces quarterly common dividend increase